ArticleJournal of virology2026
H2-O deficiency in B cells or dendritic cells drives retrovirus-neutralizing antibody responses.
Julie Dobkin, Ryan Fink, Helen Beilinson Lietuvninkas, Tatyana V Golovkina, Lisa K Denzin
Abstract read
In one paragraphArticle in Journal of virology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
5 authors.
Julie Dobkin *Child Health Institute of New Jersey, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA.
Ryan Fink *Child Health Institute of New Jersey, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA.
Helen Beilinson LietuvninkasDepartment of Microbiology, Committee on Microbiology, Committee on Immunology, Committee on Genetics, Genomics and Systems Biology, The University of Chicago, Chicago, Illinois, USA.
Tatyana V GolovkinaDepartment of Microbiology, Committee on Microbiology, Committee on Immunology, Committee on Genetics, Genomics and Systems Biology, The University of Chicago, Chicago, Illinois, USA.ORCID 0000-0002-2924-6747 Lisa K DenzinChild Health Institute of New Jersey, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA.ORCID 0000-0002-0554-4547 Funding
VIRAL ONCOLOGY CORE FACILITYP30CA014599 · NCI · UNIVERSITY OF CHICAGO · PI KUNLE ODUNSI · 1985 to 2026
$122.1MRe-Engineering Translational Research at the University of ChicagoUL1TR000430 · NCATS · UNIVERSITY OF CHICAGO · PI SOLWAY, JULIAN · 2012 to 2016
$20.2MNew retroviral restriction factorR01AI117535 · NIAID · UNIVERSITY OF CHICAGO · PI GOLOVKINA, TATYANA V · 2016 to 2020
$3.2MRetroviral infection and new modulators of the MHCII pathwayR01AI175279 · NIAID · UNIVERSITY OF CHICAGO · PI Tatyana V Golovkina · 2024 to 2026
$2.4MNew retroviral restriction factorR56AI117535 · NIAID · UNIVERSITY OF CHICAGO · PI GOLOVKINA, TATYANA V · 2021 to 2021
$776kNational Institute of Allergy and Infectious Diseases R01AI175279, R56AI117535, R01AI117535NCATS NIH HHS UL1 TR000430NCATS NIH HHS UL TR000430NCI NIH HHS P30 CA014599NIAID NIH HHS R01 AI117535NIAID NIH HHS R01 AI175279NIAID NIH HHS R56 AI117535
6 · The paper itselfAbstract
Major histocompatibility complex class II (MHC II)-restricted antigen presentation is central to CD4
Indexed as
Antibodies, NeutralizingAntibodies, ViralB-LymphocytesDendritic CellsH-2 AntigensHistocompatibility Antigens Class IIRetroviridaeAnimalsAntigen PresentationMiceMice, Inbred C57BLMice, KnockoutAntibodies, NeutralizingAntibodies, ViralH-2 AntigensHistocompatibility Antigens Class IIH2-OMHC II presenatationneutralizing antibody responsesviruses
Identifiers
PMID42671555
PMCPMC13595935
What OpenQuestion holds
Textmetadata
Read underepoch 390